These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38321618)

  • 1. Intractable pemphigus foliaceus after COVID-19 mRNA vaccination.
    Matsumoto C; Terada N; Harada Y; Takahashi M; Niiyama S; Fukuda H
    J Dermatol; 2024 Jul; 51(7):e233-e234. PubMed ID: 38321618
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases with new onset of pemphigus foliaceus after SARS-CoV-2 vaccination.
    Rouatbi J; Aounallah A; Lahouel M; Sriha B; Belajouza C; Denguezli M
    Dermatol Ther; 2022 Nov; 35(11):e15827. PubMed ID: 36111460
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.
    Martora F; Fabbrocini G; Nappa P; Megna M
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e750-e751. PubMed ID: 35679165
    [No Abstract]   [Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery.
    Ikuno Y; Yamaguchi A; Takahashi T; Fujimoto N
    Acta Derm Venereol; 2024 May; 104():adv21502. PubMed ID: 38738771
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent Skin Rash, Epigastralgia, and Arthralgia After SARS-CoV-2 mRNA Immunization and Breakthrough Infection.
    Katsube K; Nagai T; Watanabe T
    Gastroenterology; 2024 Jul; 167(2):e5-e8. PubMed ID: 38199589
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.
    Falcinelli F; Lamberti A; Cota C; Rubegni P; Cinotti E
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e976-e978. PubMed ID: 35789506
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
    Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
    JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report.
    Calogiuri G; Foti C; Congedo M; Nettis E; Paladini L; Greco G; Pavone V; Vacca A
    Endocr Metab Immune Disord Drug Targets; 2024; 24(4):495-498. PubMed ID: 37817657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination.
    Sassi M; Khefacha L; Merzigui R; Rakez R; Boukhriss S; Laatiri MA
    Br J Haematol; 2021 Dec; 195(5):649. PubMed ID: 34312842
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombocytopenia after COVID-19 vaccination.
    Kragholm K; Sessa M; Mulvad T; Andersen MP; Collatz-Christensen H; Blomberg SN; Lippert F; Mikkelsen S; Leutscher P; Melgaard D; Torp-Pedersen C; Kristensen SR; Larsen TB; Sogaard P
    J Autoimmun; 2021 Sep; 123():102712. PubMed ID: 34332437
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
    JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell vasculitis post-COVID-19 mRNA vaccine and COVID-19 asymptomatic infection: Correspondence.
    Sookaromdee P; Wiwanitkit V
    Vascular; 2024 Apr; 32(2):475. PubMed ID: 36303407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between COVID-19 vaccination and Bell's palsy.
    Cirillo N; Doan R
    Lancet Infect Dis; 2022 Jan; 22(1):5-6. PubMed ID: 34411533
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Shaw RH; Stuart A; Greenland M; Liu X; Nguyen Van-Tam JS; Snape MD;
    Lancet; 2021 May; 397(10289):2043-2046. PubMed ID: 33991480
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 19. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
    Akoglu G
    Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1?
    Vuilleumier N; Pagano S; Ludewig B; Schmiedeberg K; Haller C; von Kempis J; Rubbert-Roth A
    Eur J Clin Invest; 2022 Feb; 52(2):e13713. PubMed ID: 34841527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.